Internal Medicine · La Palma, CA
NPI
1932284817
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7872 Walker St
La Palma, CA, 90623
Phone (714) 527-8777
Groups this clinician bills Medicare through
Medicare paid, 2024
$188K
4,583 services
Medicare patients, 2024
493
Average age 74
Drug cost, 2024
$4.2M
16,478 prescriptions
Company payments, 2025
$1,413
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Winston C Wong was code J0897 (injection, denosumab, 1 mg), 1,020 times for 15 patients. In total Winston C Wong billed 4,583 services in 51 codes, and Medicare paid $188K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,020 | 15 | $20.19 | $21K |
| 99214 Office E&M - Established | Office | 845 | 326 | $91.79 | $78K |
| 99213 Office E&M - Established | Office | 484 | 269 | $63.27 | $31K |
| 81002 Clinical Chemistry | Office | 263 | 157 | $3.41 | $897 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 181 | 181 | $140.30 | $25K |
| 82962 Clinical Chemistry | Office | 143 | 87 | $3.21 | $459 |
| 93000 Electrocardiogram | Office | 118 | 108 | $10.06 | $1,187 |
| G0008 Administration of influenza virus vaccine | Office | 107 | 106 | $34.69 | $3,712 |
| 90653 Vaccine Product | Office | 104 | 104 | $81.03 | $8,427 |
| 96372 Injection Administration | Office | 103 | 46 | $10.59 | $1,091 |
| 36415 Venipuncture Blood Collection | Office | 89 | 83 | $8.65 | $770 |
| 99212 Office E&M - Established | Office | 60 | 47 | $37.37 | $2,242 |
| 85018 Blood Count | Office | 49 | 22 | $2.32 | $114 |
| 71046 X-ray - Chest | Office | 47 | 46 | $22.45 | $1,055 |
| 99203 Office E&M - New | Office | 18 | 18 | $60.38 | $1,087 |
By year: 2022 $88K for 1,943 services; 2023 $129K for 3,206 services; 2024 $188K for 4,583 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 263 | 157 | $3.41 | $897 |
| 82962 Clinical Chemistry | 143 | 87 | $3.21 | $459 |
| 36415 Venipuncture Blood Collection | 89 | 83 | $8.65 | $770 |
| 85018 Blood Count | 49 | 22 | $2.32 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Winston C Wong prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,198 prescriptions and refills. In total Winston C Wong wrote 16,478 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,198 | 3,366 | 359 | $23K |
| Atorvastatin Calcium Generic | 1,143 | 3,059 | 336 | $13K |
| Amlodipine Besylate Generic | 737 | 1,977 | 211 | $3,949 |
| Ozempic Semaglutide | 501 | 751 | 103 | $701K |
| Entresto Sacubitril/Valsartan | 432 | 817 | 96 | $521K |
| Levothyroxine Sodium Generic | 402 | 1,131 | 117 | $5,539 |
| Irbesartan Generic | 395 | 1,102 | 109 | $7,707 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 395 | 751 | 76 | $395K |
| Tamsulosin Hcl Generic | 367 | 993 | 113 | $5,635 |
| Valsartan Generic | 363 | 1,007 | 113 | $12K |
| Losartan Potassium Generic | 363 | 935 | 98 | $4,235 |
| Metoprolol Succinate Generic | 361 | 925 | 102 | $4,714 |
| Farxiga Dapagliflozin Propanediol | 346 | 633 | 80 | $334K |
| Telmisartan Generic | 314 | 840 | 100 | $9,829 |
| Omeprazole Generic | 299 | 808 | 99 | $4,215 |
Brand drugs: 3,968 claims; generic drugs: 12,422 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Winston C Wong $1,413 ($1,413 in general payments such as food, travel and fees) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $285.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $285 |
| Novo Nordisk Inc NVO | 8 | $248 |
| Amgen Inc. AMGN | 13 | $189 |
| Dexcom, Inc. DXCM | 2 | $119 |
| Gilead Sciences, Inc. GILD | 1 | $91.9 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $80.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $52.41 |
| GlaxoSmithKline, LLC. GSK | 2 | $39.08 |
| Abbvie Inc. ABBV | 2 | $34.69 |
| Axsome Therapeutics, Inc. AXSM | 1 | $32.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.